Literature DB >> 22210023

A new paradigm for stem cell therapy: substance-P as a stem cell-stimulating agent.

Hyun-Sook Hong1, Do Yeon Kim, Kang Jun Yoon, Youngsook Son.   

Abstract

Bone marrow is a reservoir for hematopoietic stem cells, endothelial precursor cells, and bone marrow stromal cells (also generally called mesenchymal stem cells), whose positive role in tissue repair is highly anticipated. In this report, we introduce a novel function of substance-P (SP), an 11-amino-acid peptide, as an injury-inducible messenger to mobilize bone marrow stem cells to the blood and finally to engage in tissue repair. This new drug may substitute for ex vivo cell culture of therapeutic cells by stimulating cell proliferation in the bone marrow in vivo and mobilizing those therapeutic cells to the patient's own blood stream. Again, the additional role of SP in mitigating inflammation-mediated tissue damage can further rationalize the clinical development of SP-peptide as a stem cell stimulant.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22210023     DOI: 10.1007/s12272-011-1221-x

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  10 in total

1.  Preparation of N-Phenyl-lactam Derivatives Capable of Stimulating Neurogenesis and Their Use in the Treatment of Neurological Disorders.

Authors:  Benjamin Blass
Journal:  ACS Med Chem Lett       Date:  2015-10-05       Impact factor: 4.345

2.  Self-assembling peptide nanofibers coupled with neuropeptide substance P for bone tissue engineering.

Authors:  Su Hee Kim; Woojune Hur; Ji Eun Kim; Hye Jeong Min; Sukwha Kim; Hye Sook Min; Byeung Kyu Kim; Soo Hyun Kim; Tae Hyun Choi; Youngmee Jung
Journal:  Tissue Eng Part A       Date:  2015-01-13       Impact factor: 3.845

3.  The effect of Substance P/Heparin conjugated PLCL polymer coating of bioinert ePTFE vascular grafts on the recruitment of both ECs and SMCs for accelerated regeneration.

Authors:  Donghak Kim; Justin J Chung; Youngmee Jung; Soo Hyun Kim
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

4.  Neuropeptide Substance-P-Conjugated Chitosan Nanofibers as an Active Modulator of Stem Cell Recruiting.

Authors:  Min Sup Kim; Sang Jun Park; Wheemoon Cho; Bon Kang Gu; Chun-Ho Kim
Journal:  Int J Mol Sci       Date:  2016-01-07       Impact factor: 5.923

Review 5.  In situ tissue regeneration through host stem cell recruitment.

Authors:  In Kap Ko; Sang Jin Lee; Anthony Atala; James J Yoo
Journal:  Exp Mol Med       Date:  2013-11-15       Impact factor: 8.718

6.  Delivery of bone morphogenetic protein-2 and substance P using graphene oxide for bone regeneration.

Authors:  Wan-Geun La; Min Jin; Saibom Park; Hee-Hun Yoon; Gun-Jae Jeong; Suk Ho Bhang; Hoyoung Park; Kookheon Char; Byung-Soo Kim
Journal:  Int J Nanomedicine       Date:  2014-05-07

7.  A Chitosan-Based Liposome Formulation Enhances the In Vitro Wound Healing Efficacy of Substance P Neuropeptide.

Authors:  Tamara Mengoni; Manuela Adrian; Susana Pereira; Beatriz Santos-Carballal; Mathias Kaiser; Francisco M Goycoolea
Journal:  Pharmaceutics       Date:  2017-12-06       Impact factor: 6.321

Review 8.  Administration of signalling molecules dictates stem cell homing for in situ regeneration.

Authors:  Xuan Li; Xiao-Tao He; Yuan Yin; Rui-Xin Wu; Bei-Min Tian; Fa-Ming Chen
Journal:  J Cell Mol Med       Date:  2017-08-02       Impact factor: 5.310

9.  Effects of Substance P for Liver Regeneration in Rat Hepatectomy Models: A Preliminary Experimental Animal Study.

Authors:  Hyunmin Ko; Young Il Kim; Hyung Joon Ahn
Journal:  Ann Transplant       Date:  2022-02-01       Impact factor: 1.530

Review 10.  Graphene-Based Biomaterials for Bone Regenerative Engineering: A Comprehensive Review of the Field and Considerations Regarding Biocompatibility and Biodegradation.

Authors:  Leila Daneshmandi; Mohammed Barajaa; Armin Tahmasbi Rad; Stefanie A Sydlik; Cato T Laurencin
Journal:  Adv Healthc Mater       Date:  2020-10-26       Impact factor: 9.933

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.